Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Multiple Myeloma 242Neoplasms, Plasma Cell 50Lymphoma 45Lymphoma, Mantle-Cell 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Non-Hodgkin 30Recurrence 29Lymphoma, Follicular 24Leukemia, Myeloid, Acute 24Lymphoma, Large B-Cell, Diffuse 23Waldenstrom Macroglobulinemia 22Lymphoma, B-Cell, Marginal Zone 20Leukemia 20Immunoglobulin Light-chain Amyloidosis 18Leukemia, Lymphocytic, Chronic, B-Cell 14Myelodysplastic Syndromes 12Carcinoma, Non-Small-Cell Lung 12Neoplasms 11Hodgkin Disease 11Burkitt Lymphoma 10Breast Neoplasms 10Lymphoma, T-Cell, Peripheral 9Lymphoma, Large-Cell, Anaplastic 9Lymphoma, B-Cell 9Lung Neoplasms 9Immunoblastic Lymphadenopathy 9Hematologic Neoplasms 9Prostatic Neoplasms 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, T-Cell 8

Interventions

Sunitinib 4Cyclophosphamide 4Capecitabine 4Bevacizumab 4pazopanib 3Topotecan 3Paclitaxel 3Docetaxel 3Carboplatin 3temsirolimus 2liposomal doxorubicin 2fludarabine 2Sorafenib 2Panobinostat 2NVP-BKM120 2Lapatinib 2Irinotecan 2Immune Checkpoint Inhibitors 2Gemcitabine 2Everolimus 2Erlotinib Hydrochloride 2Doxorubicin 2Bortezomib 2vadimezan 1spartalizumab 1somatostatin receptor 2 1selinexor 1selicrelumab 1perifosine 1pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Solid Tumors × Bortezomib × Clear all
NCT00720148 2014-08-26

A Phase I Trial of Bortezomib and Sunitinib

Emory University

Phase 1 Completed
30 enrolled
Other solid neoplasm

Solid Tumors

NCT00500422 2013-02-13

Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Completed
134 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡